The New England journal of medicine, 2017-10, Vol.377 (14), p.1319-1330
- Eikelboom, John W
- Connolly, Stuart J
- Bosch, Jackie
- Dagenais, Gilles R
- Hart, Robert G
- Shestakovska, Olga
- Diaz, Rafael
- Alings, Marco
- Lonn, Eva M
- Anand, Sonia S
- Widimsky, Petr
- Hori, Masatsugu
- Avezum, Alvaro
- Piegas, Leopoldo S
- Branch, Kelley R.H
- Probstfield, Jeffrey
- Bhatt, Deepak L
- Zhu, Jun
- Liang, Yan
- Maggioni, Aldo P
- Lopez-Jaramillo, Patricio
- O’Donnell, Martin
- Kakkar, Ajay K
- Fox, Keith A.A
- Parkhomenko, Alexander N
- Ertl, Georg
- Störk, Stefan
- Keltai, Matyas
- Ryden, Lars
- Pogosova, Nana
- Dans, Antonio L
- Lanas, Fernando
- Commerford, Patrick J
- Torp-Pedersen, Christian
- Guzik, Tomek J
- Verhamme, Peter B
- Vinereanu, Dragos
- Kim, Jae-Hyung
- Tonkin, Andrew M
- Lewis, Basil S
- Felix, Camilo
- Yusoff, Khalid
- Steg, P. Gabriel
- Metsarinne, Kaj P
- Cook Bruns, Nancy
- Misselwitz, Frank
- Chen, Edmond
- Leong, Darryl
- Yusuf, Salim
2017
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Eikelboom, John W
- Connolly, Stuart J
- Bosch, Jackie
- Dagenais, Gilles R
- Hart, Robert G
- Shestakovska, Olga
- Diaz, Rafael
- Alings, Marco
- Lonn, Eva M
- Anand, Sonia S
- Widimsky, Petr
- Hori, Masatsugu
- Avezum, Alvaro
- Piegas, Leopoldo S
- Branch, Kelley R.H
- Probstfield, Jeffrey
- Bhatt, Deepak L
- Zhu, Jun
- Liang, Yan
- Maggioni, Aldo P
- Lopez-Jaramillo, Patricio
- O’Donnell, Martin
- Kakkar, Ajay K
- Fox, Keith A.A
- Parkhomenko, Alexander N
- Ertl, Georg
- Störk, Stefan
- Keltai, Matyas
- Ryden, Lars
- Pogosova, Nana
- Dans, Antonio L
- Lanas, Fernando
- Commerford, Patrick J
- Torp-Pedersen, Christian
- Guzik, Tomek J
- Verhamme, Peter B
- Vinereanu, Dragos
- Kim, Jae-Hyung
- Tonkin, Andrew M
- Lewis, Basil S
- Felix, Camilo
- Yusoff, Khalid
- Steg, P. Gabriel
- Metsarinne, Kaj P
- Cook Bruns, Nancy
- Misselwitz, Frank
- Chen, Edmond
- Leong, Darryl
- Yusuf, Salim
- Titel
- Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
- Ist Teil von
- The New England journal of medicine, 2017-10, Vol.377 (14), p.1319-1330
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2017
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- In patients with stable cardiovascular disease, those receiving rivaroxaban plus aspirin had fewer major cardiovascular events but more major bleeding events than those receiving aspirin alone. Rivaroxaban alone did not result in fewer major cardiovascular events than aspirin alone.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793eISSN: 1533-4406DOI: 10.1056/NEJMoa1709118Titel-ID: cdi_hal_primary_oai_HAL_hal_01892329v1
- Format
- –
- Schlagworte
- Aged, Arteriosclerosis, Aspirin, Aspirin - adverse effects, Aspirin - therapeutic use, Atherosclerosis, Atherosclerosis - complications, Atherosclerosis - drug therapy, Bleeding, Cardiovascular disease, Cardiovascular Diseases - drug therapy, Cardiovascular Diseases - mortality, Cardiovascular Diseases - prevention & control, Cerebral infarction, Coronary vessels, Disease prevention, Double-Blind Method, Drug dosages, Drug therapy, Drug Therapy, Combination, Factor Xa Inhibitors - adverse effects, Factor Xa Inhibitors - therapeutic use, Female, Hemorrhage - chemically induced, Human health and pathology, Humans, Life Sciences, Male, Medical research, Middle Aged, Myocardial infarction, Platelet Aggregation Inhibitors - adverse effects, Platelet Aggregation Inhibitors - therapeutic use, Rivaroxaban - adverse effects, Rivaroxaban - therapeutic use, Secondary Prevention - methods